Structure

Physi-Chem Properties

Molecular Weight:  348.06
Volume:  326.231
LogP:  4.107
LogD:  2.154
LogS:  -7.292
# Rotatable Bonds:  0
TPSA:  105.98
# H-Bond Aceptor:  6
# H-Bond Donor:  4
# Rings:  7
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.364
Synthetic Accessibility Score:  4.925
Fsp3:  0.2
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.201
MDCK Permeability:  3.99941473006038e-06
Pgp-inhibitor:  0.001
Pgp-substrate:  0.012
Human Intestinal Absorption (HIA):  0.608
20% Bioavailability (F20%):  0.029
30% Bioavailability (F30%):  0.997

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.006
Plasma Protein Binding (PPB):  93.03125762939453%
Volume Distribution (VD):  0.552
Pgp-substrate:  8.480840682983398%

ADMET: Metabolism

CYP1A2-inhibitor:  0.67
CYP1A2-substrate:  0.054
CYP2C19-inhibitor:  0.053
CYP2C19-substrate:  0.065
CYP2C9-inhibitor:  0.418
CYP2C9-substrate:  0.936
CYP2D6-inhibitor:  0.583
CYP2D6-substrate:  0.146
CYP3A4-inhibitor:  0.047
CYP3A4-substrate:  0.032

ADMET: Excretion

Clearance (CL):  1.243
Half-life (T1/2):  0.47

ADMET: Toxicity

hERG Blockers:  0.006
Human Hepatotoxicity (H-HT):  0.205
Drug-inuced Liver Injury (DILI):  0.99
AMES Toxicity:  0.813
Rat Oral Acute Toxicity:  0.228
Maximum Recommended Daily Dose:  0.054
Skin Sensitization:  0.89
Carcinogencity:  0.632
Eye Corrosion:  0.004
Eye Irritation:  0.723
Respiratory Toxicity:  0.297

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC215593

Natural Product ID:  NPC215593
Common Name*:   CJGDIPRCPKGNLW-AHYXFKKWSA-N
IUPAC Name:   n.a.
Synonyms:  
Standard InCHIKey:  CJGDIPRCPKGNLW-AHYXFKKWSA-N
Standard InCHI:  InChI=1S/C20H12O6/c21-7-3-1-5-9-12(18-20(26-18)15(23)13(7)9)6-2-4-8(22)14-10(6)11(5)17-19(25-17)16(14)24/h1-4,11-12,17-22H/t11-,12-,17+,18+,19-,20-/m0/s1
SMILES:  O=C1[C@@H]2O[C@@H]2[C@@H]2c3c1c(O)ccc3[C@H]1c3c2ccc(c3C(=O)[C@H]2[C@@H]1O2)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3338990
PubChem CID:   114895
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000025] Phenanthrenes and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33081 alternaria tenuissima que1se Species Pleosporaceae Eukaryota endophyte of Quercus emoryi n.a. n.a. PMID[25260957]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT27 Others Unspecified Ratio CC50/IC50 = 15.0 n.a. PMID[529606]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 IC50 = 290.0 nM PMID[529606]
NPT24 Organism Human immunodeficiency virus 1 Human immunodeficiency virus 1 Inhibition = 97.0 % PMID[529606]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC215593 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9648 High Similarity NPC472134
0.958 High Similarity NPC472135
0.9514 High Similarity NPC142846
0.8836 High Similarity NPC85310
0.8759 High Similarity NPC114620
0.8759 High Similarity NPC103337
0.8707 High Similarity NPC308572
0.8707 High Similarity NPC469520
0.8636 High Similarity NPC478133
0.8591 High Similarity NPC84568
0.8591 High Similarity NPC48130
0.8591 High Similarity NPC218866
0.8591 High Similarity NPC300684
0.8543 High Similarity NPC119767
0.8533 High Similarity NPC170055
0.8516 High Similarity NPC314257
0.8491 Intermediate Similarity NPC290160
0.8431 Intermediate Similarity NPC477221
0.8431 Intermediate Similarity NPC120171
0.8418 Intermediate Similarity NPC184326
0.8418 Intermediate Similarity NPC292863
0.8414 Intermediate Similarity NPC472262
0.8414 Intermediate Similarity NPC287604
0.8414 Intermediate Similarity NPC161964
0.84 Intermediate Similarity NPC313047
0.84 Intermediate Similarity NPC474203
0.84 Intermediate Similarity NPC295712
0.84 Intermediate Similarity NPC451542
0.8389 Intermediate Similarity NPC477275
0.8389 Intermediate Similarity NPC106519
0.8389 Intermediate Similarity NPC91019
0.8366 Intermediate Similarity NPC290695
0.8366 Intermediate Similarity NPC106524
0.8365 Intermediate Similarity NPC137232
0.8365 Intermediate Similarity NPC18380
0.8365 Intermediate Similarity NPC478134
0.8355 Intermediate Similarity NPC285122
0.8355 Intermediate Similarity NPC147250
0.8354 Intermediate Similarity NPC195167
0.8345 Intermediate Similarity NPC52407
0.8345 Intermediate Similarity NPC314048
0.8344 Intermediate Similarity NPC471906
0.8333 Intermediate Similarity NPC474517
0.8333 Intermediate Similarity NPC239136
0.8333 Intermediate Similarity NPC72669
0.8333 Intermediate Similarity NPC19631
0.8323 Intermediate Similarity NPC477276
0.8323 Intermediate Similarity NPC205918
0.8312 Intermediate Similarity NPC478219
0.8311 Intermediate Similarity NPC13715
0.8301 Intermediate Similarity NPC162751
0.8301 Intermediate Similarity NPC52161
0.8301 Intermediate Similarity NPC290194
0.828 Intermediate Similarity NPC266469
0.8278 Intermediate Similarity NPC174905
0.8278 Intermediate Similarity NPC296752
0.8278 Intermediate Similarity NPC293545
0.8276 Intermediate Similarity NPC70622
0.8267 Intermediate Similarity NPC110810
0.8247 Intermediate Similarity NPC94781
0.8224 Intermediate Similarity NPC477913
0.8224 Intermediate Similarity NPC79627
0.8224 Intermediate Similarity NPC227841
0.8217 Intermediate Similarity NPC474824
0.8217 Intermediate Similarity NPC182921
0.8217 Intermediate Similarity NPC470408
0.8217 Intermediate Similarity NPC218870
0.8212 Intermediate Similarity NPC257644
0.8212 Intermediate Similarity NPC474961
0.82 Intermediate Similarity NPC225243
0.8194 Intermediate Similarity NPC99731
0.8182 Intermediate Similarity NPC5568
0.817 Intermediate Similarity NPC478160
0.8158 Intermediate Similarity NPC471682
0.8158 Intermediate Similarity NPC354984
0.8146 Intermediate Similarity NPC305845
0.8146 Intermediate Similarity NPC204045
0.8141 Intermediate Similarity NPC477914
0.8141 Intermediate Similarity NPC315520
0.8138 Intermediate Similarity NPC199253
0.8138 Intermediate Similarity NPC136588
0.8133 Intermediate Similarity NPC190457
0.8133 Intermediate Similarity NPC26924
0.8121 Intermediate Similarity NPC261292
0.8121 Intermediate Similarity NPC301915
0.8121 Intermediate Similarity NPC305060
0.8117 Intermediate Similarity NPC470570
0.8113 Intermediate Similarity NPC474861
0.8108 Intermediate Similarity NPC80035
0.8108 Intermediate Similarity NPC283088
0.8105 Intermediate Similarity NPC21599
0.8105 Intermediate Similarity NPC244691
0.8105 Intermediate Similarity NPC193703
0.8105 Intermediate Similarity NPC48762
0.8105 Intermediate Similarity NPC29932
0.8101 Intermediate Similarity NPC209393
0.8101 Intermediate Similarity NPC205172
0.8101 Intermediate Similarity NPC478218
0.8101 Intermediate Similarity NPC472211
0.8099 Intermediate Similarity NPC173978
0.8095 Intermediate Similarity NPC225051
0.8095 Intermediate Similarity NPC267205
0.8095 Intermediate Similarity NPC78307
0.8092 Intermediate Similarity NPC137649
0.8092 Intermediate Similarity NPC135524
0.8086 Intermediate Similarity NPC478229
0.8086 Intermediate Similarity NPC315772
0.8082 Intermediate Similarity NPC41847
0.8079 Intermediate Similarity NPC315578
0.8079 Intermediate Similarity NPC181560
0.8079 Intermediate Similarity NPC169452
0.8077 Intermediate Similarity NPC280753
0.8077 Intermediate Similarity NPC44378
0.8075 Intermediate Similarity NPC284495
0.8067 Intermediate Similarity NPC173980
0.8065 Intermediate Similarity NPC37709
0.8061 Intermediate Similarity NPC300307
0.8054 Intermediate Similarity NPC191976
0.8054 Intermediate Similarity NPC155211
0.8054 Intermediate Similarity NPC474813
0.8054 Intermediate Similarity NPC86524
0.8052 Intermediate Similarity NPC474630
0.8052 Intermediate Similarity NPC34482
0.8052 Intermediate Similarity NPC12402
0.8052 Intermediate Similarity NPC471683
0.805 Intermediate Similarity NPC82190
0.805 Intermediate Similarity NPC192219
0.805 Intermediate Similarity NPC174599
0.8042 Intermediate Similarity NPC103540
0.8041 Intermediate Similarity NPC50924
0.8041 Intermediate Similarity NPC44437
0.8039 Intermediate Similarity NPC100242
0.8039 Intermediate Similarity NPC478164
0.8038 Intermediate Similarity NPC474534
0.8038 Intermediate Similarity NPC474533
0.8027 Intermediate Similarity NPC478190
0.8027 Intermediate Similarity NPC309430
0.8027 Intermediate Similarity NPC17843
0.8026 Intermediate Similarity NPC246638
0.8025 Intermediate Similarity NPC205766
0.8025 Intermediate Similarity NPC316457
0.8025 Intermediate Similarity NPC472261
0.8013 Intermediate Similarity NPC138099
0.8013 Intermediate Similarity NPC242994
0.8012 Intermediate Similarity NPC53139
0.8012 Intermediate Similarity NPC295090
0.8 Intermediate Similarity NPC53414
0.8 Intermediate Similarity NPC283480
0.8 Intermediate Similarity NPC143685
0.8 Intermediate Similarity NPC53206
0.8 Intermediate Similarity NPC245923
0.8 Intermediate Similarity NPC51513
0.8 Intermediate Similarity NPC148323
0.8 Intermediate Similarity NPC478223
0.8 Intermediate Similarity NPC202112
0.8 Intermediate Similarity NPC282923
0.8 Intermediate Similarity NPC475957
0.8 Intermediate Similarity NPC471905
0.8 Intermediate Similarity NPC247250
0.8 Intermediate Similarity NPC767
0.8 Intermediate Similarity NPC136878
0.8 Intermediate Similarity NPC314437
0.7987 Intermediate Similarity NPC70859
0.7987 Intermediate Similarity NPC283590
0.7987 Intermediate Similarity NPC61153
0.7987 Intermediate Similarity NPC130899
0.7975 Intermediate Similarity NPC187934
0.7975 Intermediate Similarity NPC97637
0.7975 Intermediate Similarity NPC15374
0.7974 Intermediate Similarity NPC474300
0.7974 Intermediate Similarity NPC193555
0.7974 Intermediate Similarity NPC73061
0.7973 Intermediate Similarity NPC115458
0.7973 Intermediate Similarity NPC171968
0.7972 Intermediate Similarity NPC234890
0.7972 Intermediate Similarity NPC74507
0.7964 Intermediate Similarity NPC4200
0.7962 Intermediate Similarity NPC329933
0.7961 Intermediate Similarity NPC168471
0.7961 Intermediate Similarity NPC155205
0.7961 Intermediate Similarity NPC96421
0.7959 Intermediate Similarity NPC93015
0.7959 Intermediate Similarity NPC205992
0.7959 Intermediate Similarity NPC244699
0.7959 Intermediate Similarity NPC85342
0.7959 Intermediate Similarity NPC471851
0.7952 Intermediate Similarity NPC175477
0.795 Intermediate Similarity NPC317580
0.7949 Intermediate Similarity NPC478018
0.7949 Intermediate Similarity NPC476821
0.7947 Intermediate Similarity NPC61398
0.7947 Intermediate Similarity NPC416
0.7945 Intermediate Similarity NPC276238
0.7937 Intermediate Similarity NPC3449
0.7937 Intermediate Similarity NPC66029
0.7937 Intermediate Similarity NPC474501
0.7933 Intermediate Similarity NPC254847
0.7933 Intermediate Similarity NPC291454
0.7933 Intermediate Similarity NPC272268
0.7933 Intermediate Similarity NPC38158

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC215593 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8224 Intermediate Similarity NPD7390 Discontinued
0.8143 Intermediate Similarity NPD1201 Approved
0.8042 Intermediate Similarity NPD1470 Approved
0.7933 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7914 Intermediate Similarity NPD6959 Discontinued
0.7881 Intermediate Similarity NPD5405 Approved
0.7881 Intermediate Similarity NPD5404 Approved
0.7881 Intermediate Similarity NPD5408 Approved
0.7881 Intermediate Similarity NPD5406 Approved
0.7821 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7707 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7607 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD3300 Phase 2
0.7578 Intermediate Similarity NPD4380 Phase 2
0.7546 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7516 Intermediate Similarity NPD3226 Approved
0.7514 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7486 Intermediate Similarity NPD8150 Discontinued
0.7484 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7471 Intermediate Similarity NPD3751 Discontinued
0.7468 Intermediate Similarity NPD1510 Phase 2
0.7456 Intermediate Similarity NPD6166 Phase 2
0.7456 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.744 Intermediate Similarity NPD3787 Discontinued
0.7439 Intermediate Similarity NPD7819 Suspended
0.7436 Intermediate Similarity NPD1549 Phase 2
0.7414 Intermediate Similarity NPD8313 Approved
0.7414 Intermediate Similarity NPD8312 Approved
0.7412 Intermediate Similarity NPD7473 Discontinued
0.741 Intermediate Similarity NPD7075 Discontinued
0.7401 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD1934 Approved
0.7355 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7342 Intermediate Similarity NPD7003 Approved
0.7337 Intermediate Similarity NPD6232 Discontinued
0.7333 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD1512 Approved
0.7326 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.732 Intermediate Similarity NPD943 Approved
0.7303 Intermediate Similarity NPD3764 Approved
0.7301 Intermediate Similarity NPD7458 Discontinued
0.7278 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD2534 Approved
0.7267 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD2532 Approved
0.7267 Intermediate Similarity NPD2533 Approved
0.7261 Intermediate Similarity NPD2346 Discontinued
0.7251 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7238 Intermediate Similarity NPD6535 Approved
0.7238 Intermediate Similarity NPD6534 Approved
0.7233 Intermediate Similarity NPD8166 Discontinued
0.7226 Intermediate Similarity NPD1607 Approved
0.7222 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD7411 Suspended
0.7208 Intermediate Similarity NPD1240 Approved
0.7205 Intermediate Similarity NPD1511 Approved
0.7197 Intermediate Similarity NPD2935 Discontinued
0.7169 Intermediate Similarity NPD6801 Discontinued
0.7166 Intermediate Similarity NPD8320 Phase 1
0.7166 Intermediate Similarity NPD8319 Approved
0.7143 Intermediate Similarity NPD3882 Suspended
0.7143 Intermediate Similarity NPD7768 Phase 2
0.7143 Intermediate Similarity NPD6797 Phase 2
0.7143 Intermediate Similarity NPD3019 Approved
0.7135 Intermediate Similarity NPD6777 Approved
0.7135 Intermediate Similarity NPD6782 Approved
0.7135 Intermediate Similarity NPD6779 Approved
0.7135 Intermediate Similarity NPD6781 Approved
0.7135 Intermediate Similarity NPD6778 Approved
0.7135 Intermediate Similarity NPD6780 Approved
0.7135 Intermediate Similarity NPD6776 Approved
0.7134 Intermediate Similarity NPD3299 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD5844 Phase 1
0.7125 Intermediate Similarity NPD3750 Approved
0.712 Intermediate Similarity NPD7699 Phase 2
0.712 Intermediate Similarity NPD7700 Phase 2
0.7118 Intermediate Similarity NPD5494 Approved
0.7112 Intermediate Similarity NPD7435 Discontinued
0.7102 Intermediate Similarity NPD7251 Discontinued
0.7101 Intermediate Similarity NPD3749 Approved
0.7101 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7091 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7089 Intermediate Similarity NPD2796 Approved
0.7086 Intermediate Similarity NPD1164 Approved
0.7083 Intermediate Similarity NPD3817 Phase 2
0.7081 Intermediate Similarity NPD6190 Approved
0.7074 Intermediate Similarity NPD7870 Phase 2
0.7074 Intermediate Similarity NPD7871 Phase 2
0.7062 Intermediate Similarity NPD7808 Phase 3
0.7048 Intermediate Similarity NPD6599 Discontinued
0.7037 Intermediate Similarity NPD7211 Clinical (unspecified phase)
0.7032 Intermediate Similarity NPD6663 Approved
0.7027 Intermediate Similarity NPD2932 Approved
0.7025 Intermediate Similarity NPD2799 Discontinued
0.7024 Intermediate Similarity NPD2801 Approved
0.7021 Intermediate Similarity NPD7697 Approved
0.7021 Intermediate Similarity NPD7698 Approved
0.7021 Intermediate Similarity NPD7696 Phase 3
0.7012 Intermediate Similarity NPD6273 Approved
0.6994 Remote Similarity NPD6799 Approved
0.6993 Remote Similarity NPD5736 Approved
0.6989 Remote Similarity NPD7074 Phase 3
0.6982 Remote Similarity NPD5402 Approved
0.6968 Remote Similarity NPD2313 Discontinued
0.6966 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6951 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6949 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6941 Remote Similarity NPD4868 Clinical (unspecified phase)
0.6937 Remote Similarity NPD2344 Approved
0.6937 Remote Similarity NPD1471 Phase 3
0.6932 Remote Similarity NPD7054 Approved
0.6914 Remote Similarity NPD4628 Phase 3
0.6902 Remote Similarity NPD6213 Phase 3
0.6902 Remote Similarity NPD6212 Phase 3
0.6902 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6893 Remote Similarity NPD7472 Approved
0.6892 Remote Similarity NPD9545 Approved
0.6891 Remote Similarity NPD7874 Approved
0.6891 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6879 Remote Similarity NPD4060 Phase 1
0.6875 Remote Similarity NPD7701 Phase 2
0.6875 Remote Similarity NPD3818 Discontinued
0.6875 Remote Similarity NPD7177 Discontinued
0.6867 Remote Similarity NPD5403 Approved
0.6856 Remote Similarity NPD7801 Approved
0.6852 Remote Similarity NPD2800 Approved
0.6851 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6848 Remote Similarity NPD5401 Approved
0.6846 Remote Similarity NPD4196 Clinical (unspecified phase)
0.6829 Remote Similarity NPD7236 Approved
0.6821 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6818 Remote Similarity NPD2798 Approved
0.6816 Remote Similarity NPD6559 Discontinued
0.6813 Remote Similarity NPD3748 Approved
0.6797 Remote Similarity NPD1283 Approved
0.6778 Remote Similarity NPD5026 Approved
0.6778 Remote Similarity NPD5028 Approved
0.6778 Remote Similarity NPD4954 Approved
0.6778 Remote Similarity NPD36 Approved
0.6778 Remote Similarity NPD4955 Approved
0.6778 Remote Similarity NPD5034 Approved
0.677 Remote Similarity NPD1551 Phase 2
0.6768 Remote Similarity NPD2309 Approved
0.6755 Remote Similarity NPD3026 Approved
0.6755 Remote Similarity NPD3023 Approved
0.6753 Remote Similarity NPD8151 Discontinued
0.6743 Remote Similarity NPD5710 Approved
0.6743 Remote Similarity NPD5711 Approved
0.6733 Remote Similarity NPD3025 Approved
0.6733 Remote Similarity NPD3024 Approved
0.6722 Remote Similarity NPD5030 Phase 2
0.6721 Remote Similarity NPD5038 Approved
0.6721 Remote Similarity NPD5037 Approved
0.6713 Remote Similarity NPD2342 Discontinued
0.6702 Remote Similarity NPD6823 Phase 2
0.6687 Remote Similarity NPD6651 Approved
0.6686 Remote Similarity NPD1247 Approved
0.6686 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6685 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6667 Remote Similarity NPD1608 Approved
0.6667 Remote Similarity NPD3091 Approved
0.6667 Remote Similarity NPD6099 Approved
0.6667 Remote Similarity NPD919 Approved
0.6667 Remote Similarity NPD2861 Phase 2
0.6667 Remote Similarity NPD6100 Approved
0.6667 Remote Similarity NPD2979 Phase 3
0.6667 Remote Similarity NPD5036 Approved
0.6646 Remote Similarity NPD6798 Discontinued
0.6646 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6645 Remote Similarity NPD3094 Phase 2
0.6634 Remote Similarity NPD8155 Clinical (unspecified phase)
0.6632 Remote Similarity NPD8285 Discontinued
0.663 Remote Similarity NPD5027 Approved
0.663 Remote Similarity NPD8434 Phase 2
0.663 Remote Similarity NPD5031 Approved
0.663 Remote Similarity NPD5029 Approved
0.6628 Remote Similarity NPD8455 Phase 2
0.6628 Remote Similarity NPD1465 Phase 2
0.6627 Remote Similarity NPD7239 Suspended
0.6625 Remote Similarity NPD230 Phase 1
0.6625 Remote Similarity NPD6355 Discontinued
0.6623 Remote Similarity NPD1651 Approved
0.662 Remote Similarity NPD1237 Approved
0.6606 Remote Similarity NPD3400 Discontinued
0.6603 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6601 Remote Similarity NPD1281 Approved
0.6601 Remote Similarity NPD3092 Approved
0.6599 Remote Similarity NPD7635 Approved
0.6597 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6596 Remote Similarity NPD4360 Phase 2
0.6596 Remote Similarity NPD4363 Phase 3
0.6587 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6582 Remote Similarity NPD7008 Discontinued
0.6581 Remote Similarity NPD1876 Approved
0.6578 Remote Similarity NPD5968 Phase 3
0.6571 Remote Similarity NPD6234 Discontinued
0.657 Remote Similarity NPD37 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data